News

Advanced Dermatology and Cosmetic Surgery Acquires Esterson Dermatology

BALTIMORE, June 28, 2022 (GLOBE NEWSWIRE) -- Today Advanced Dermatology and Cosmetic Surgery, one of the country’s leading dermatology practices,…

2 years ago

Indegene Partners with Amwell to Empower Life Sciences Organizations with Unparalleled Patient Support Solutions

PRINCETON, N.J., June 28, 2022 (GLOBE NEWSWIRE) -- Indegene, a technology-led healthcare solutions provider, today announced a partnership with Amwell®,…

2 years ago

Aleafia Health Announces Closing of Debenture Amendment Transaction

TORONTO, June 28, 2022 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is…

2 years ago

Pure Extracts Receives Purchase Order for a New Listing of High-Potency Vape Carts from the Ontario Cannabis Store

VANCOUVER, British Columbia, June 28, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure…

2 years ago

Healthy Extracts Enters Retail Marketplace, Launching Brain Health Products in Over 160 Natural Grocers® Stores Nationwide

Nation's Largest Family-Operated Organic & Natural Grocer Healthy Extracts launches in over 160 Natural Grocers Stores nationwide. UBN ACTIVATE™ UBN…

2 years ago

Hepion Pharmaceuticals Further Strengthens Board with Appointments of Accomplished Biopharmaceutical Executives, Mr. Anand Reddi and Dr. Kaouthar Lbiati

EDISON, N.J., June 28, 2022 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical mid-stage biopharmaceutical company focused on Artificial…

2 years ago

Aleafia Health Announces Record $43.1 Million Net Revenue in 2022 15-Month Fiscal Year, Strong $8 Million Branded Cannabis Net Revenue in Q5

151% increase in branded cannabis net revenue1 to $36.8 million in 15-month fiscal year 2022 ended March 31, 2022 (new…

2 years ago

Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic

The OncoSignature® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely…

2 years ago

ProSomnus® to Open New Global Headquarters and Manufacturing Center of Excellence, Increasing Manufacturing Capacity and Efficiency

32,219-square-foot facility will quintuple growth and create local jobs All ProSomnus medical devices are made in Pleasanton, CA, USA SAN…

2 years ago

Larimar Therapeutics Announces Oral Presentation at the Upcoming Gordon Research Conference on Mitochondria and Chloroplasts

BALA CYNWYD, Pa., June 28, 2022 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused…

2 years ago